Champions Oncology ( NASDAQ:CSBR ) Third Quarter 2025 Results Key Financial Results Revenue: US$17.0m (up 42% from 3Q... HACKENSACK, NJ / ACCESS Newswire / March 11, 2025 / Champions Oncology ...

Champions Oncology , Inc. (NASDAQ:CSBR) stock soared to a 52-week high, reaching $10.91, marking a significant milestone for the company specializing in advanced technology solutions and services ...

Market Open. HACKENSACK, NJ / ACCESS Newswire / March 11, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end ...

CHAMPIONS ONCOLOGY ($CSBR) posted quarterly earnings results on Tuesday, March 11th. The company reported earnings of $0.31 per share, beating estimates of -$0.01 by ...

CHAMPIONS ONCOLOGY ($CSBR) is expected to release its quarterly earnings data on Tuesday, March 11th before market open, per Finnhub. Analysts are expecting revenue ...

Craig-Hallum analyst Matt Hewitt reiterated a Buy rating on Champions Oncology (CSBR – Research Report) today. The company’s shares closed last Friday at $9.94. See what stocks are receiving ...